Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: Etiology, outcome, and treatment

Epilepsia

Volumn 37, Issue SUPPL. 1, 1996, Pages

  Mitchell, Wendy G ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Adolescent; Adult; Adverse drug reaction; Anticonvulsants; Brain diagnosis; Child; Epilepsy; Seizures; Status epilepticus; Treatment outcome

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PARALDEHYDE; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ANTICONVULSANT THERAPY; CLINICAL PROTOCOL; DRUG CHOICE; EPILEPTIC STATE; HUMAN; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; TREATMENT OUTCOME;

EID: 0029943483     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb06025.x     Document Type: Review

References (53)

1. Dieckmann RA. Rectal diazepam for prehospital pediatric status epilepticus. Ann Emerg Med 1994;23:16-24.
2. Kriel RL, Cloyd JC, Hadsall RS, Carlson AM, Floren KL, Jones-Saete CM. Home use of rectal diazepam for cluster and prolonged seizures: efficacy, adverse reactions, quality of life, and cost analysis. Pediatr Neurol 1991;7:13-7.
3. Lacroix J, Deal C, Gauthier M, Rousseau E, Farrell CA. Admissions to a pediatric intensive care unit for status epilepticus: a 10-year experience. Crit Care Med 1994;22:827-32.
4. Maytal J, Shinnar S, Moshé SL, Alvarez LA. Low morbidity and mortality of status epilepticus in children. Pediatrics 1989;83:323-31.
5. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483-8.
6. Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia 1993;34:1033-7.
7. Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status epilepticus. Neurology 1990;40(suppl 2):23-7.
8. Verity CM, Ross EM, Golding J. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. BMJ 1993;307:225-8.
9. Berg AT, Shinnar S. The contributions of epidemiology to the understanding of childhood seizures and epilepsy. J Child Neurol 1994;9(suppl 2): 19-26.
10. Shinnar S, Maytal J, Krasnoff L, Moshé SL. Recurrent status epilepticus in children. Ann Neurol 1992;31:598-604.
11. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR. Very high dose phenobarbital for refractory status epilepticus in children. Neurology 1988;38:1035-40.
12. Van Ness PC. Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990;31:61-7.
13. Crawford TO, Mitchell WG, Snodgrass SR. Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis. Neurology 1987;37:190-5.
14. Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990;40(suppl 2):32-42.
15. Chiulli DA, Terndrup TE, Kanter RK. The influence of diazepam or lorazepam on the frequency of endotracheal intubation in childhood status epilepticus. J Emerg Med 1991; 9:13-7.
16. Richard MO, Chiron C, d'Athis P, et al. Phenytoin monitoring in status epilepticus in infants and children. Epilepsia 1993;34:144-50.
17. Mirski MA, Williams MA, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995;23:400-4.
18. Eriksson K, Baer M, Kilpinen P, Koivikko M. Effects of long barbiturate anaesthesia on eight children with severe epilepsy. Neuropediatrics 1993;24:281-5.
19. Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993;43:895-900.
20. Bertz RJ, Howrie DL. Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome. Ann Pharmacother 1993;27:298-301.
21. Gherpelli JL, Luccas FJ, Roitman I, Troster EJ. Midazolam for treatment of refractory neonatal seizures. A case report. Arq Neuropsiquiatr 1994;52:260-2.
22. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992; 20:483-8.
23. Rivera R, Segnini M, Baltodano A, Perez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993;21:991-4.
24. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994;44:1837-40.
25. Labar DR, Ali A, Root J. High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology 1994;44:1400-3.
26. Aggarwal P. Wali JP. Lidocaine in refractory status epilepticus: a forgotten drug in the emergency department. Am J Emerg Med 1993;11:243-4.
27. Caria MA, Mameli O, De Riu PL, et al. Propofol anticonvulsant activity in experimental epileptic status. Br J Anaesth 1992;69:177-81.
28. Kofke WA, Towfighi J, Garman RH, Graybeal JM, Housman C, Hawkins RA. Effects of anesthetics on neuropathologic sequelae of status epilepticus in rats. Anesth Analg 1993;77:330-7.
29. Hasan MM, Hasan ZA, al-Hadar AF, Takrouri MS. The anticonvulsant effects of propofol, diazepam, and thiopental, against picrotoxin-induced seizure in the rat. Middle East J Anesth 1993;12:113-21.
30. Heavner JE, Arthur J, Zou J, McDaniel K, Tyman-Szram B, Rosenberg PH. Comparison of propofol with thiopentone for treatment of bupivacaine-induced seizures in rats. Br J Anaesth 1993;71:715-9.
31. Borgeat A, Wilder Smith OH, Jallon P, Suter PM. Propofol in the management of refractory status epilepticus: a case report. Intens Care Med 1994;20:148-9.
32. Kuisma M, Roine RO. Propofol in prehospilal treatment of convulsive status epilepticus. Epilepsia 1995;36:1241-3.
33. Exil G, Clancy RR, Hyder DJ. Propofol treatment of refractory status epilepticus. A report of five pediatric cases. Epilepsia 1995;36(suppl 4):528.
34. McBurney JW, Teiken PJ, Moon MR. Propofol for treating status epilepticus. J Epilepsy 1994;7:21-2.
35. Fujikawa DG. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 1995;36:186-95.
36. Stewart CA, Reid IC. Ketamine prevents ECS-induced synaptic enhancement in rat hippocampus. Neurosci Lett 1994; 178:11-4.
37. Cascino GD. Nonconvulsive status epilepticus in adults and children. Epilepsia 1993;34(suppl 1):s21-8.
38. Drislane FW, Schomer DL. Clinical implications of generalized electrographic status epilepticus. Epilepsy Res 1994; 19:111-21.
39. Brodtkorb E, Sand T, Kristiansen A, Torbergsen T. Non-convulsive status epilepticus in the adult mentally retarded. Classification and role of benzodiazepines. Seizure 1993;2: 115-23.
40. Thomas P, Lebrun C, Chatel M. De novo absence status epilepticus as a benzodiazepine withdrawal syndrome. Epilepsia 1993;34:355-8.
41. Callahan DJ, Noetzel MJ. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992;42:2198-201.
42. Baram TZ, Mitchell WG, Snead OC III. The prognostic significance of acute epilepsia partialis continua. Pediatr Neurol 1991;7:144-6.
43. Gorman DG, Shields WD, Shewmon DA, et al. Neurosurgical treatment of refractory status epilepticus. Epilepsia 1992;33:546-9.
44. Camfield CS, Camfield PR, Smith E, Dooley JM. Home use of rectal diazepam to prevent status epilepticus in children with convulsive disorders. J Child Neurol 1989;4:125-6.
45. Moolenaar F, Bakker S, Visser J, Huizinga T. Biopharmaceutics of rectal administration of drugs in man IX: Comparative biopharmaceutics of diazepam after single rectal, oral, intramuscular and intravenous administration in man. Int J Pharmaceut 1980;5:127-37.
46. Langslet A, Bemerg A, Bredesen JE, Lunde PKM. Plasma concentrations of diazepam and N-desmethyldiazepam in newborn infants after intravenous, intramuscular, rectal and oral administration. Acta Paediatr Scand 1978;67:699-704.
47. Knudsen FU. Plasma-diazepam in infants after rectal administration in solution and by suppository. Acta Paediatr Scand 1977;66:563-7.
48. Graves NM, Kriel RL, Jones-Saete C. Bioavailability of rectally administered lorazepam. Clin Neuropharmacol 1987; 10:555-9.
49. Bebin M, Bleck TP. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Drugs 1994;48:153-71.
50. De Giorgio CM, Altman K, Hamilton-Byrd E, Rabinowicz AL. Lidocaine in refractory status epilepticus: confirmation of efficacy with continuous EEG monitoring. Epilepsia 1992; 33:913-6.
51. Pascual J, Sedano MJ, Polo JM, Berciano J. Intravenous lidocaine for status epilepticus. Epilepsia 1988;29:584-9.
52. Bertz RJ, Howrie DL. Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome. Ann Pharmacother 1993;27:298-301.
53. Thong YH, Abramson DC. Continuous infusion of diazepam in infants with severe recurrent convulsions. Med Ann Dist Columbia 1974;43:63-5.